Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-20-051389

SVP, COO & CFO sold 2,000 shares at $19.96 ($39,920)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Labrucherie Gil M SVP, COO & CFO 2020-09-17 Sale −2,000 $19.96 $39,920 235,249 D: show line 1 in the form
Open-market sales · 2,000 sh · avg $19.96 · $39,920
Loading xslF345X03/doc4.xml…